Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...

Shares of the company ended 1.6% lower at a price of ₹354.40 on the BSE. Last week's losses have dragged the stock 4% lower ...

Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE: 532523, NSE: BIOCON), today announced that the U.S. Food and Drug Administration (FDA) ...

Find out how single-use optical technology enables accurate, non-invasive cell monitoring in rocking motion bioreactor setups ...

The FDA approved a supplemental new drug application for Tremfya for the treatment of children aged 6 years or older with ...

Hidradenitis suppurativa (HS) may affect 1 in 100 people. Lily is now speaking up so no one else has to suffer in silence.

A 36-year-old woman is accused of impersonating a medical professional to steal medication from a patient at Saint Thomas Midtown in Nashville earlier this month. The incident happened on Wednesday ...

Shares of Biocon Ltd rose 2% to Rs 361.25 on the BSE after its subsidiary, Biocon Biologics, received U.S. FDA approval for ...

Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE code: 532523, NSE: ...

TREMFYA® is now approved for pediatric patients living with moderate to severe plaque psoriasis, who are candidates for systemic therapy or phototherapy, and active ...